Yüklüyor......
Delta and Kappa Opioid Receptor Polymorphisms Influence the Effects of Naltrexone on Subjective Responses to Alcohol
Naltrexone, one of four FDA-approved pharmacotherapies for alcohol dependence, has shown moderate efficacy in clinical trials. Pharmacogenetic effects have been reported such that allelic variation at the gene encoding the mu-opioid receptor (OPRM1, rs1799971) predicts naltrexone-induced blunting of...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3683577/ https://ncbi.nlm.nih.gov/pubmed/22954510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pbb.2012.08.019 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|